We are monitoring the impact of COVID-19 on Asia Pacific Perfusion Systems Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3412
Share on
Share on

Asia Pacific Perfusion Systems Market Research Report - Segmented By Component, Type, Technique & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecast To 2025

Pulished: February, 2020
ID: 3412
Pages: 145

Asia Pacific Perfusion Systems Market Size & Growth (2020 – 2025):

According to the report, the Size of the Perfusion Systems Market in Asia Pacific is valued at USD 0.24 billion in 2020 and projected to grow at a CAGR of 2.9%, to reach USD 0.28 billion by 2025 during the forecast period 2020-2025. 

Perfusion is the process of oxygenated blood being delivered to the tissues of the body. Perfusion of the body's tissues occurs during Systole. The chambers contract, and the oxygenated blood is forced into the arteries. These arteries carry the blood to the tissues where the oxygen is removed. The unoxygenated blood is then returned to the heart via veins, and the process begins again after the blood is reoxygenated by the lungs. The only exception to this is the perfusion of the heart itself. The heart actually perfuses during diastole when the cardiac muscle is relaxed and the blood is pulled into the cardiac tissue.

The critical factor driving the growth of this market is Increasing Investments in Cell-Based Research in developed as well as developing further propels the growth of this market. An increase in Biologic Manufacturing also further drive market growth. The limiting factors for market growth are stringent rules of compliance. Also, the High Cost of Organ Transplantation, Ethical Concerns and High Cost of Cell-Based Research and tough competition from local companies with low-cost products are hampers the growth of this market.

Asia Pacific Perfusion Systems Market has been segmented and sub-segmented into the following categories

  • By Component: Heart-lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas
  • By Type: Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity/Pressure-driven Perfusion Systems, Small-mammal Organ Perfusion Systems
  • By Technique: Hypothermic Machine Perfusion Systems, & Normothermic Machine Perfusion Systems.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

On the basis of type, the bioreactor perfusion systems segment holds the major share of the perfusion systems market in 2018 and is projected to record the highest CAGR during the forecast period.

On the basis of the region, China and India are likely to increase the market because of a huge population. Also, Asia Pacific is the largest growing segment.

Top Companies dominating the Asia Pacific Perfusion Systems Market Profiled in the Report are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories, Inc, Merck KGaA, Harvard Bioscience, Inc, ALA Scientific Instruments, Inc.,

1.Introduction         

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions 

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary 

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints     

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Component 

                                5.1.1 Heart-lung Machines                                          

                                5.1.2 Perfusion Pumps                                  

                                5.1.3 Oxygenators                                          

                                5.1.4 Monitoring Systems                                            

                                5.1.5 Cannulas                                  

                                5.1.6 Other Components                                             

                                5.1.7  Y-o-Y Growth Analysis, By Component                                      

                                5.1.8  Market Attractiveness Analysis, By Component                                    

                                5.1.9  Market Share Analysis, By Component                                      

                5.2 Type     

                                5.2.1 Bioreactor Perfusion Systems                                         

                                5.2.2 Microfluidic Perfusion Systems                                      

                                5.2.3 Gravity/Pressure-driven Perfusion Systems                                            

                                5.2.4 Small-mammal Organ Perfusion Systems                                  

                                5.2.5 Y-o-Y Growth Analysis, By Type                                     

                                5.2.6 Market Attractiveness Analysis, By Type                                   

                                5.2.7 Market Share Analysis, By Type                                     

                5.3 Technique    

                                5.3.1 Hypothermic Machine Perfusion Systems                                 

                                5.3.2 Normothermic Machine Perfusion Systems                                             

                                5.3.4 Y-o-Y Growth Analysis, By Technique                                          

                                5.3.5  Market Attractiveness Analysis, By Technique                                       

                                5.3.6  Market Share Analysis, By Technique                                         

6. Geographical Analysis                     

                6.1 Introduction      

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

   6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Component                

                                                6.1.3.3 By Type

                                                6.1.3.4 By Technique                     

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Component                  

  6.1.4.3 By Type                 

  6.1.4.4 By Technique                     

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Component                  

6.1.5.3 By Type                 

6.1.5.4 By Technique                     

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia       

7.Strategic Analysis               

                7.1 PESTLE analysis

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis     

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                

                8.1 AB (Sweden)    

                                8.1.1 Overview                                 

                                8.1.2 Component Analysis                                           

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Medtronic plc (Ireland),         

                8.3 LivaNova PLC (U.K.) 

                8.4 Terumo Corporation (Japan)      

                8.5 XENIOS AG (Germany) 

                8.6 ALA Scientific Instruments, Inc. (U.S.)    

                8.7 Repligen Corporation (U.S.) 

                8.8 Spectrum Laboratories, Inc. (U.S.)     

                8.9 Merck KGaA (Germany)        

                8.10 Harvard Bioscience, Inc. (U.S.)

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables 

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Perfusion Systems Market By Component, From 2020-2025 ( USD Billion )
  2. Asia-Pacific Heart-lung Machines Market By Region, From 2020-2025 ( USD Billion )
  3. Asia-Pacific Perfusion Pumps Market By Region, From 2020-2025 ( USD Billion )
  4. Asia-Pacific Oxygenators Market By Region, From 2020-2025 ( USD Billion )
  5. Asia-Pacific Monitoring Systems Market By Region, From 2020-2025 ( USD Billion )
  6. Asia-Pacific Cannulas Market By Region, From 2020-2025 ( USD Billion )
  7. Asia-Pacific Other Components Market By Region, From 2020-2025 ( USD Billion )
  8. Asia-Pacific Perfusion Systems Market By Type, From 2020-2025 ( USD Billion )
  9. Asia-Pacific Bioreactor Perfusion Systems Market By Region, From 2020-2025 ( USD Billion )
  10. Asia-Pacific Microfluidic Perfusion Systems Market By Region, From 2020-2025 ( USD Billion )
  11. Asia-Pacific Gravity/Pressure-driven Perfusion Systems Market By Region, From 2020-2025 ( USD Billion )
  12. Asia-Pacific Small-mammal Organ Perfusion Systems Market By Region, From 2020-2025 ( USD Billion )
  13. Asia-Pacific Perfusion Systems Market By  Technique, From 2020-2025 ( USD Billion )
  14. Asia-Pacific Hypothermic Machine Perfusion Systems Market By Region, From 2020-2025 ( USD Billion )
  15. Asia-Pacific Normothermic Machine Perfusion Systems Market By Region, From 2020-2025 ( USD Billion )
  16. Japan Perfusion Systems Market By Component, From 2020-2025 ( USD Billion )
  17. Japan Perfusion Systems Market By Type, From 2020-2025 ( USD Billion )
  18. Japan Perfusion Systems Market By  Technique, From 2020-2025 ( USD Billion )
  19. China Perfusion Systems Market By Component, From 2020-2025 ( USD Billion )
  20. China Perfusion Systems Market By Type, From 2020-2025 ( USD Billion )
  21. China Perfusion Systems Market By  Technique, From 2020-2025 ( USD Billion )
  22. India Perfusion Systems Market By Component, From 2020-2025 ( USD Billion )
  23. India Perfusion Systems Market By Type, From 2020-2025 ( USD Billion )
  24. India Perfusion Systems Market By  Technique, From 2020-2025 ( USD Billion )
  25. Australia Perfusion Systems Market By Component, From 2020-2025 ( USD Billion )
  26. Australia Perfusion Systems Market By Type, From 2020-2025 ( USD Billion )
  27. Australia Perfusion Systems Market By  Technique, From 2020-2025 ( USD Billion )
  28. South Korea Perfusion Systems Market By Component, From 2020-2025 ( USD Billion )
  29. South Korea Perfusion Systems Market By Type, From 2020-2025 ( USD Billion )
  30. South Korea Perfusion Systems Market By  Technique, From 2020-2025 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample